Table of Content
Table of Content
1 Oral Biologics & Biosimilar Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Oral Biologics & Biosimilar Drugs
1.3 Oral Biologics & Biosimilar Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Oral Biologics & Biosimilar Drugs Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Oral Biologics & Biosimilar Drugs
1.4.2 Applications of Oral Biologics & Biosimilar Drugs
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Oral Biologics & Biosimilar Drugs Industry Trends
1.5.2 Oral Biologics & Biosimilar Drugs Drivers
1.5.3 Oral Biologics & Biosimilar Drugs Market Challenges
1.5.4 Oral Biologics & Biosimilar Drugs Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Oral Biologics & Biosimilar Drugs Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Oral Biologics & Biosimilar Drugs Industry Development
2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Oral Biologics & Biosimilar Drugs Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Oral Biologics & Biosimilar Drugs
2.2.1 Major Players Manufacturing Base of Oral Biologics & Biosimilar Drugs in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Oral Biologics & Biosimilar Drugs Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Oral Biologics & Biosimilar Drugs
2.3.3 Labor Cost of Oral Biologics & Biosimilar Drugs
2.4 Market Channel Analysis of Oral Biologics & Biosimilar Drugs
2.5 Major Down Stream Customers by Application
3 Global Oral Biologics & Biosimilar Drugs Market, by Type
3.1 Global Oral Biologics & Biosimilar Drugs Revenue and Market Share by Type (2018-2021)
3.2 Global Oral Biologics & Biosimilar Drugs Production and Market Share by Type (2018-2021)
3.3 Global Oral Biologics & Biosimilar Drugs Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Oral Biologics & Biosimilar Drugs Revenue and Growth Rate of Vaccines
3.3.2 Global Oral Biologics & Biosimilar Drugs Revenue and Growth Rate of Proteins & Peptides
3.3.3 Global Oral Biologics & Biosimilar Drugs Revenue and Growth Rate of Monoclonal Antibodies
3.3.4 Global Oral Biologics & Biosimilar Drugs Revenue and Growth Rate of Others
3.4 Global Oral Biologics & Biosimilar Drugs Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends
4 Oral Biologics & Biosimilar Drugs Market, by Application
4.1 Downstream Market Overview
4.2 Global Oral Biologics & Biosimilar Drugs Consumption and Market Share by Application (2018-2021)
4.3 Global Oral Biologics & Biosimilar Drugs Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Oral Biologics & Biosimilar Drugs Consumption and Growth Rate of Hospital Pharmacies (2018-2021)
4.3.2 Global Oral Biologics & Biosimilar Drugs Consumption and Growth Rate of Retail Pharmacies (2018-2021)
4.3.3 Global Oral Biologics & Biosimilar Drugs Consumption and Growth Rate of Online Pharmacies (2018-2021)
5 Global Oral Biologics & Biosimilar Drugs Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Oral Biologics & Biosimilar Drugs Revenue and Market Share by Region (2018-2021)
5.2 Global Oral Biologics & Biosimilar Drugs Consumption and Market Share by Region (2018-2021)
5.3 Global Oral Biologics & Biosimilar Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Oral Biologics & Biosimilar Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Oral Biologics & Biosimilar Drugs Market Under COVID-19
5.4.2 North America Oral Biologics & Biosimilar Drugs SWOT Analysis
5.5 Europe Oral Biologics & Biosimilar Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Oral Biologics & Biosimilar Drugs Market Under COVID-19
5.5.2 Europe Oral Biologics & Biosimilar Drugs SWOT Analysis
5.6 China Oral Biologics & Biosimilar Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Oral Biologics & Biosimilar Drugs Market Under COVID-19
5.6.2 China Oral Biologics & Biosimilar Drugs SWOT Analysis
5.7 Japan Oral Biologics & Biosimilar Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Oral Biologics & Biosimilar Drugs Market Under COVID-19
5.7.2 Japan Oral Biologics & Biosimilar Drugs SWOT Analysis
5.8 Middle East and Africa Oral Biologics & Biosimilar Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Oral Biologics & Biosimilar Drugs Market Under COVID-19
5.8.2 Middle East and Africa Oral Biologics & Biosimilar Drugs SWOT Analysis
5.9 India Oral Biologics & Biosimilar Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Oral Biologics & Biosimilar Drugs Market Under COVID-19
5.9.2 India Oral Biologics & Biosimilar Drugs SWOT Analysis
5.10 South America Oral Biologics & Biosimilar Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Oral Biologics & Biosimilar Drugs Market Under COVID-19
5.10.2 South America Oral Biologics & Biosimilar Drugs SWOT Analysis
5.11 South Korea Oral Biologics & Biosimilar Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Oral Biologics & Biosimilar Drugs Market Under COVID-19
5.11.2 South Korea Oral Biologics & Biosimilar Drugs SWOT Analysis
5.12 Southeast Asia Oral Biologics & Biosimilar Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Oral Biologics & Biosimilar Drugs Market Under COVID-19
5.12.2 Southeast Asia Oral Biologics & Biosimilar Drugs SWOT Analysis
6 Global Oral Biologics & Biosimilar Drugs Production by Top Regions (2018-2021)
6.1 Global Oral Biologics & Biosimilar Drugs Production by Top Regions (2018-2021)
6.2 North America Oral Biologics & Biosimilar Drugs Production and Growth Rate
6.3 Europe Oral Biologics & Biosimilar Drugs Production and Growth Rate
6.4 China Oral Biologics & Biosimilar Drugs Production and Growth Rate
6.5 Japan Oral Biologics & Biosimilar Drugs Production and Growth Rate
6.6 India Oral Biologics & Biosimilar Drugs Production and Growth Rate
7 Global Oral Biologics & Biosimilar Drugs Consumption by Regions (2018-2021)
7.1 Global Oral Biologics & Biosimilar Drugs Consumption by Regions (2018-2021)
7.2 North America Oral Biologics & Biosimilar Drugs Consumption and Growth Rate
7.3 Europe Oral Biologics & Biosimilar Drugs Consumption and Growth Rate
7.4 China Oral Biologics & Biosimilar Drugs Consumption and Growth Rate
7.5 Japan Oral Biologics & Biosimilar Drugs Consumption and Growth Rate
7.6 Middle East & Africa Oral Biologics & Biosimilar Drugs Consumption and Growth Rate
7.7 India Oral Biologics & Biosimilar Drugs Consumption and Growth Rate
7.8 South America Oral Biologics & Biosimilar Drugs Consumption and Growth Rate
7.9 South Korea Oral Biologics & Biosimilar Drugs Consumption and Growth Rate
7.10 Southeast Asia Oral Biologics & Biosimilar Drugs Consumption and Growth Rate
8 Competitive Landscape
8.1 Competitive Profile
8.2 Eli Lilly and Co. Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Oral Biologics & Biosimilar Drugs Product Profiles, Application and Specification
8.2.3 Eli Lilly and Co. Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Novo Nordisk A/S Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Oral Biologics & Biosimilar Drugs Product Profiles, Application and Specification
8.3.3 Novo Nordisk A/S Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Novartis Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Oral Biologics & Biosimilar Drugs Product Profiles, Application and Specification
8.4.3 Novartis Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 AstraZeneca plc Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Oral Biologics & Biosimilar Drugs Product Profiles, Application and Specification
8.5.3 AstraZeneca plc Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Rani Therapeutics Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Oral Biologics & Biosimilar Drugs Product Profiles, Application and Specification
8.6.3 Rani Therapeutics Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
9 Global Oral Biologics & Biosimilar Drugs Market Analysis and Forecast by Type and Application
9.1 Global Oral Biologics & Biosimilar Drugs Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Vaccines Market Revenue and Volume Forecast (2021-2026)
9.1.2 Proteins & Peptides Market Revenue and Volume Forecast (2021-2026)
9.1.3 Monoclonal Antibodies Market Revenue and Volume Forecast (2021-2026)
9.1.4 Others Market Revenue and Volume Forecast (2021-2026)
9.2 Global Oral Biologics & Biosimilar Drugs Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Hospital Pharmacies Market Revenue and Volume Forecast (2021-2026)
9.2.2 Retail Pharmacies Market Revenue and Volume Forecast (2021-2026)
9.2.3 Online Pharmacies Market Revenue and Volume Forecast (2021-2026)
10 Oral Biologics & Biosimilar Drugs Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Oral Biologics & Biosimilar Drugs Market Trends Analysis
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?
